Original Article ACE variants and association with brain Aβ levels in Alzheimer’s disease
J. Scott Miners, Merryn Raiker, Seth Love, Patrick G. Kehoe
Dementia Research Group, Institute of Clinical Neurosciences, Clinical Science at North Bristol, University of Bristol, BS16 1LE, UK; Department of Neuropathology, Institute of Clinical Neurosciences, Clinical Science at North Bristol, University of Bristol, BS16 1LE, UK.
Abstract: ACE is a candidate gene for Alzheimer’s disease (AD) and associations have been reported between ACE variants and plasma ACE levels, AD risk, AD age at onset of disease and cerebrospinal fluid levels of Aβ. Despite evidence that ACE can degrade Aβ, the relationships between ACE variants and the levels of different types of Aβ in the brain are not known. We have investigated the relationship between AD-associated ACE variants, for which the associations with brain activity of ACE were previously analysed, and brain homogenate levels of soluble, insoluble and oligomeric Aβ. Reported AD risk variants in the ACE indel (rs1799752) and its ‘proxy’ rs4343 were significantly associated with soluble Aβ level in AD only (p=0.001), as was rs1800764 but less so (p=0.014). In contrast, insoluble Aβ was associated with ACE indel and rs4343 variants in controls only (p < 0.01). No associations were found for oligomeric Aβ. These data indicate a complex relationship between ACE and Aβ that differs between AD and control brains. (AJTR1009001).
Address all correspondence to: Patrick G. Kehoe, PhD Dementia Research Group Institute of Clinical Neurosciences Clinical Science at North Bristol University of Bristol, BS16 1LE, UK. Tel: +44-117-340-6607 E-mail: Patrick.Kehoe@bristol.ac.uk